OVERVIEW

The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.
 
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
 
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be a 2-day live meeting to discuss recent updates in the care of patients with solid and hematologic malignancies.  A virtual live stream option will also be available for participants unable to travel.

TARGET AUDIENCE

This activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and other healthcare professionals interested in the treatment and diagnosis of lymphoma.

LEARNING OBJECTIVES

At the conclusion of this educational activity, participants will be able to:

• Debate the selection and sequencing of the latest advances to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma;
• Assess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma;
• Evaluate clinical trial data of current and emerging cellular therapy/CAR T-cell approaches for patients with lymphoma, including important safety and efficacy data;
• Review specific patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL;
• Acquire strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.